After a year on therapy, 54% to 57% of patients on Tasigna had no signs of leukemia using the most sensitive test vs. just 30% of those who were on Gleevec.
She quickly returned home and from the moment she got off the plane to resume her battle with leukemia, she issued an order to her parents: no moping and no tears.
In another path-breaking example, consider the case of Dr. Lucas Wartman, a young physician who developed adult acute lymphoblastic leukemia, a disease that is usually rapidly fatal, and for which there is no effective treatment.